Heart device under Post-Market watch: jewel P-WCD registry launches
NCT ID NCT07256678
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This observational registry will follow over 6,000 people who have been prescribed the Jewel P-WCD, a wearable defibrillator that can detect and treat dangerous heart rhythms. The goal is to confirm the device continues to work safely and effectively in everyday life. No new treatments are being tested; instead, researchers will collect data from routine commercial use.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Jewel P-WCD (wearable cardioverter defibrillator)
- What this could lead to
- If successful, this study will confirm that the Jewel P-WCD works safely and effectively in everyday use, supporting its continued availability for people at risk of sudden cardiac arrest.
- What could go wrong
- This is an observational registry, not a controlled trial, so it cannot prove cause and effect. Results may be influenced by how patients use the device in real life.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for JEWEL-P WCD are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.